CLINICAL_TRIALS
trial_result
· 2023-07-21
Clinical Trial Update: Study to Assess the Absorption, Metabolism, Excretion, and Mass Balance of CT1812 in Healthy Adult Male Subjects [Phase 1]
Summary
Phase 1 study assessing absorption, metabolism, excretion, and mass balance of CT1812 in healthy adult male subjects; completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Cognition Therapeutics | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED | Results posted: 2023-07-21